BSX - Boston Scientific Corp. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $60.26B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.40 | 1.43%
Avg Daily Range (30 D): $0.74 | 1.60%
Avg Daily Range (90 D): $0.75 | 1.60%
Institutional Daily Volume
Avg Daily Volume: 10.09M
Avg Daily Volume (30 D): 15.5M
Avg Daily Volume (90 D): 16.46M
Trade Size
Avg Trade Size (Sh.): 234
Avg Trade Size (Sh.) (30 D): 115
Avg Trade Size (Sh.) (90 D): 117
Institutional Trades
Total Institutional Trades: 113,177
Avg Institutional Trade: $3.53M
Avg Institutional Trade (30 D): $6.22M
Avg Institutional Trade (90 D): $5.76M
Avg Institutional Trade Volume: .11M
Avg Institutional Trades (Per Day): 19
Market Closing Trades
Avg Closing Trade: $32.43M
Avg Closing Trade (30 D): $160.06M
Avg Closing Trade (90 D): $137.8M
Avg Closing Volume: 775.69K
 
News
Oct 8, 2026 @ 12:00 PM
Boston Scientific Corporation (BSX) is Attracting ...
Source: Zacks.Com
Oct 6, 2026 @ 5:00 PM
Global Bioelectronic Medicine Market Anticipates I...
Source: Delveinsight
Oct 6, 2026 @ 2:38 PM
Can J&J's MedTech Business Rebound in Q3 After Q2 ...
Source: Na
Oct 2, 2026 @ 9:00 PM
Boston Scientific (BSX) Stock Sinks As Market Gain...
Source: Zacks.Com
Oct 2, 2026 @ 1:00 PM
Can ISRG Offset China Weakness With Expansion in I...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $2.49 $.62 $.9
Diluted EPS $2.47 $.61 $.9
Revenue $21B $5.44B $5.2B
Gross Profit $14.68B $3.85B $3.61B
Net Income / Loss $3.67B $905M $1.34B
Operating Income / Loss $4.15B $1.18B $1.1B
Cost of Revenue $6.32B $1.59B $1.59B
Net Cash Flow $12M $-891M $-503M
PE Ratio    
Splits
Nov 06, 2003 2:1